The increased occurrence of IIM-related skin changes in patients with SAE antibodies was confirmed in our cohort, whereas this tendency was not as clear in our TIF1γ group [25]. This evidence concerns the gene TRIM33 and acquired idiopathic inflammatory myopathy.